Tau‐PET is superior to phospho‐tau when predicting cognitive decline in symptomatic AD patients.

MLA

Smith, Ruben, et al. “Tau‐PET Is Superior to Phospho‐tau When Predicting Cognitive Decline in Symptomatic AD Patients.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 19, no. 6, June 2023, pp. 2497–507. EBSCOhost, https://doi.org/10.1002/alz.12875.

APA

Smith, R., Cullen, N. C., Pichet Binette, A., Leuzy, A., Blennow, K., Zetterberg, H., Klein, G., Borroni, E., Ossenkoppele, R., Janelidze, S., Palmqvist, S., Mattsson, C. N., Stomrud, E., & Hansson, O. (2023). Tau‐PET is superior to phospho‐tau when predicting cognitive decline in symptomatic AD patients. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 19(6), 2497–2507. https://doi.org/10.1002/alz.12875

Chicago

Smith, Ruben, Nicholas C. Cullen, Alexa Pichet Binette, Antoine Leuzy, Kaj Blennow, Henrik Zetterberg, Gregory Klein, et al. 2023. “Tau‐PET Is Superior to Phospho‐tau When Predicting Cognitive Decline in Symptomatic AD Patients.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 19 (6): 2497–2507. doi:10.1002/alz.12875.